Amarin Corp Plc (AMRN)

[Biobillionair]

Babr-

weak marketing to say the least so far.

Agree. But Amarin first needs to get approval through The Office of Prescription Drug Promotion (OPDP).

Here’s more about OPDP:

https://www.fda.gov/about-fda/center-drug-evaluation-and-research-cder/office-prescription-drug-promotion-opdp

We know the above process is ongoing because Amarin has stated its ongoing and FDA hasn’t been brave enough to release REDUCE-IT clinical trial snapshot here:

https://www.fda.gov/drugs/drug-approvals-and-databases/drug-trials-snapshots

Is Amarin 100% satisfied with label...my opinion is no; FDA should have had a lower TG and prevention of cardiovascular death in indications. Again, this is just my opinion and I don’t care to waste time on nuances of label wording...my only point FDA & Amarin will spend too much time on OPDP process because CDER f’d up labeling....hence marketing delayed until end of Q2.

BB